Azenta, Inc.
AZTA
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $1.4B
$31.33
▲ +0.48%
P/E
-76.41
Mkt Cap
$1.4B
52-Wk Range
$15.93–$41.73
52-Week Range
$15.93 - $41.73
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Integrated end-to-end sample management solutions across products and services
- Proprietary automation and cold chain technology with high switching costs
- Established relationships with major pharmaceutical and biotech companies
- Global infrastructure and multi-geography operational capabilities
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Turning profitable
Increased pharmaceutical R&D spending and drug development pipeline expansion
Value
Extreme premium - high expectations embedded
Momentum
Hot
+38.0% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying AZTA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 17, 2026
AUG 4, 2026
Reported EPS of $0.16 vs $0.11 consensus (+40.6% surprise). Revenue of $161.2M vs $149.3M expected (+8.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+40.6%
Revenue trend · last 8Q
—
—
—
+5%
-0%
+6%
+1%
+12%
Q3 24
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
Q3 26
$144.3M
$150.6M
$147.4M
$143.4M
$143.9M
$159.2M
$148.6M
$161.2M
Margins · last 8Q
Gross
44.9%
Operating
-0.9%
Profit
1.5%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Needham · May 6, 2026
vs Industry
How AZTA stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related